|
ATE386506T1
(de)
*
|
1995-10-17 |
2008-03-15 |
Jagotec Ag |
Verabreichung unlöslicher arzneistoffe
|
|
US6465016B2
(en)
*
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
|
GB9703673D0
(en)
*
|
1997-02-21 |
1997-04-09 |
Bradford Particle Design Ltd |
Method and apparatus for the formation of particles
|
|
US20080213378A1
(en)
*
|
1998-10-01 |
2008-09-04 |
Elan Pharma International, Ltd. |
Nanoparticulate statin formulations and novel statin combinations
|
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
|
US8236352B2
(en)
*
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
|
WO2000018374A1
(en)
*
|
1998-10-01 |
2000-04-06 |
Elan Pharma International, Ltd. |
Controlled release nanoparticulate compositions
|
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
US6428814B1
(en)
*
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
|
US20040141925A1
(en)
*
|
1998-11-12 |
2004-07-22 |
Elan Pharma International Ltd. |
Novel triamcinolone compositions
|
|
US20090104273A1
(en)
*
|
1999-06-22 |
2009-04-23 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
|
US20040115134A1
(en)
*
|
1999-06-22 |
2004-06-17 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
|
AU7999800A
(en)
*
|
1999-10-07 |
2001-05-10 |
Battelle Memorial Institute |
Method and apparatus for obtaining a suspension of particles
|
|
ATE283048T1
(de)
|
1999-12-08 |
2004-12-15 |
Pharmacia Corp |
Cyclooxygenase-2 hemmer enthaltende zusammensetzungen mit schnellem wirkungseintritt
|
|
EP1242112A4
(en)
*
|
1999-12-21 |
2005-02-09 |
Rxkinetix Inc |
PRODUCTS CONTAINING MEDICINANT SUBSTANCE PARTICLES AND PROCESS FOR PREPARING THE SAME
|
|
US6761909B1
(en)
*
|
1999-12-21 |
2004-07-13 |
Rxkinetix, Inc. |
Particulate insulin-containing products and method of manufacture
|
|
JP4751556B2
(ja)
|
2000-02-28 |
2011-08-17 |
ジーンシーグス, インコーポレイテッド |
ナノカプセルカプセル化システムおよび方法
|
|
PT1263413E
(pt)
*
|
2000-03-09 |
2006-08-31 |
Univ Ohio State Res Found |
Metodo de preparacao de dispersoes solidas
|
|
US20040156872A1
(en)
*
|
2000-05-18 |
2004-08-12 |
Elan Pharma International Ltd. |
Novel nimesulide compositions
|
|
AR035642A1
(es)
|
2000-05-26 |
2004-06-23 |
Pharmacia Corp |
Uso de una composicion de celecoxib para el alivio rapido del dolor
|
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
US7276249B2
(en)
*
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
US20080241070A1
(en)
*
|
2000-09-21 |
2008-10-02 |
Elan Pharma International Ltd. |
Fenofibrate dosage forms
|
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
|
US6541542B2
(en)
*
|
2000-09-29 |
2003-04-01 |
Eastman Chemical Company |
Process for production of polymeric powders
|
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
|
US6951656B2
(en)
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US9700866B2
(en)
*
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
|
US6977085B2
(en)
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
|
US20050048126A1
(en)
*
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
|
US6869617B2
(en)
|
2000-12-22 |
2005-03-22 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
EP1269994A3
(en)
*
|
2001-06-22 |
2003-02-12 |
Pfizer Products Inc. |
Pharmaceutical compositions comprising drug and concentration-enhancing polymers
|
|
EP1404438A2
(en)
*
|
2001-07-12 |
2004-04-07 |
Eastman Kodak Company |
A surfactant assisted nanomaterial generation process
|
|
GB0119480D0
(en)
|
2001-08-09 |
2001-10-03 |
Jagotec Ag |
Novel compositions
|
|
JP2005504090A
(ja)
|
2001-09-26 |
2005-02-10 |
バクスター・インターナショナル・インコーポレイテッド |
分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製
|
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
|
AU2002334939A1
(en)
*
|
2001-10-12 |
2003-04-22 |
Eugene R. Cooper |
Compositions having a combination of particles for immediate release and for controlled release
|
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
|
CA2475092C
(en)
*
|
2002-02-04 |
2012-05-01 |
Baudax Bio, Inc. |
Nanoparticulate compositions having lysozyme as a surface stabilizer
|
|
US20040101566A1
(en)
*
|
2002-02-04 |
2004-05-27 |
Elan Pharma International Limited |
Novel benzoyl peroxide compositions
|
|
EP1478386A4
(en)
*
|
2002-02-25 |
2005-12-28 |
Phasex Corp |
METHOD OF DRYING WATER-BASED MATERIALS
|
|
EP1490030B2
(en)
*
|
2002-03-20 |
2010-07-14 |
Elan Pharma International Limited |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
US20080220075A1
(en)
*
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
US20040038303A1
(en)
*
|
2002-04-08 |
2004-02-26 |
Unger Gretchen M. |
Biologic modulations with nanoparticles
|
|
WO2003088951A1
(en)
*
|
2002-04-15 |
2003-10-30 |
Eiffel Technologies Limited |
Formulation of fine particles using liquefied or dense gases
|
|
FR2838356B1
(fr)
*
|
2002-04-15 |
2004-05-28 |
Separex Sa |
Procede d'obtention d'une suspension stable de particules dans un liquide
|
|
US20070264348A1
(en)
*
|
2002-05-24 |
2007-11-15 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
AU2003245313A1
(en)
*
|
2002-06-10 |
2003-12-22 |
Elan Pharma International, Ltd |
Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives (statins), novel combinations thereof as well as manufacturing of these pharmaceutical compositions
|
|
WO2004006959A1
(en)
*
|
2002-07-16 |
2004-01-22 |
Elan Pharma International, Ltd |
Liquid dosage compositions of stable nanoparticulate active agents
|
|
UY27939A1
(es)
|
2002-08-21 |
2004-03-31 |
Glaxo Group Ltd |
Compuestos
|
|
ATE411010T1
(de)
|
2002-12-13 |
2008-10-15 |
Jagotec Ag |
Topische nanopartikel-spironolacton-formulierung
|
|
GB0229714D0
(en)
*
|
2002-12-20 |
2003-01-29 |
Glaxo Group Ltd |
Novel apparatus and method
|
|
WO2005013938A1
(ja)
*
|
2003-08-06 |
2005-02-17 |
Eisai Co., Ltd. |
薬物超微粒子の製造法及び製造装置
|
|
US20050258288A1
(en)
*
|
2003-11-26 |
2005-11-24 |
E. I. Du Pont De Nemours And Company |
High pressure media milling system and process of forming particles
|
|
US7582275B1
(en)
|
2004-01-26 |
2009-09-01 |
The United States Of America As Represented By The Secretary Of The Air Force |
Method of processing filamentary nanocarbon
|
|
US20050170063A1
(en)
*
|
2004-01-29 |
2005-08-04 |
Lalit Chordia |
Production of powder and viscous material
|
|
JP2007520555A
(ja)
*
|
2004-02-05 |
2007-07-26 |
バクスター・インターナショナル・インコーポレイテッド |
自己安定化剤の使用により調製された分散剤
|
|
GB0406515D0
(en)
*
|
2004-03-23 |
2004-04-28 |
Novartis Ag |
Organic compounds
|
|
KR101179393B1
(ko)
*
|
2004-03-23 |
2012-09-07 |
노파르티스 아게 |
제약 조성물
|
|
EP1730516A1
(en)
*
|
2004-03-30 |
2006-12-13 |
Pfizer Products Incorporated |
Method and device for evaluation of pharmaceutical compositions
|
|
PL1731138T3
(pl)
*
|
2004-03-31 |
2016-10-31 |
|
Drobnoziarnista dyspersja słabo rozpuszczalnego leku i sposób jej wytwarzania
|
|
US7754243B2
(en)
*
|
2004-08-03 |
2010-07-13 |
Clemson University Research Foundation |
Aqueous suspension of nanoscale drug particles from supercritical fluid processing
|
|
US7293570B2
(en)
*
|
2004-12-13 |
2007-11-13 |
Cool Clean Technologies, Inc. |
Carbon dioxide snow apparatus
|
|
ES2265262B1
(es)
|
2005-01-31 |
2008-03-01 |
Activery Biotech, S.L.(Titular Al 50%) |
Procedimiento para la obtencion de sistemas micro- y nanodispersos.
|
|
CA2606861C
(en)
*
|
2005-05-05 |
2012-08-07 |
Sanofi-Aventis U.S. Llc |
Stable nanoparticle formulations
|
|
US20060280787A1
(en)
*
|
2005-06-14 |
2006-12-14 |
Baxter International Inc. |
Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
|
|
US20060280786A1
(en)
*
|
2005-06-14 |
2006-12-14 |
Rabinow Barrett E |
Pharmaceutical formulations for minimizing drug-drug interactions
|
|
JP2007007524A
(ja)
*
|
2005-06-29 |
2007-01-18 |
Kagawa Industry Support Foundation |
超臨界溶液急速冷却法による単分散超微粒子の製造方法及び装置
|
|
ES2292300B1
(es)
*
|
2005-07-19 |
2009-02-16 |
Sociedad Española De Carburos Metalicos, S.A.(Titular Al 50%) |
Procedimiento para la obtencion de un material compuesto.
|
|
WO2007009986A2
(en)
*
|
2005-07-19 |
2007-01-25 |
Activery Biotech, S.L. |
Process for obtaining a composite
|
|
US7608461B1
(en)
*
|
2005-09-16 |
2009-10-27 |
Sandia Corporation |
Surface engineered nanoparticles for improved surface enhanced Raman scattering applications and method for preparing same
|
|
DE102005053862A1
(de)
*
|
2005-11-04 |
2007-05-10 |
Pharmasol Gmbh |
Verfahren und Vorrichtung zur Herstellung hochfeiner Partikel sowie zur Beschichtung solcher Partikel
|
|
BRPI0618661A2
(pt)
*
|
2005-11-15 |
2011-09-06 |
Baxter Int |
composições de inibidores de lipoxigenase
|
|
ZA200804379B
(en)
*
|
2005-12-16 |
2009-09-30 |
Unilever Plc |
Surface-active material and its application
|
|
WO2008002568A2
(en)
*
|
2006-06-26 |
2008-01-03 |
Mutual Pharmaceutical Company, Inc. |
Active agent formulations, methods of making, and methods of use
|
|
RU2009118469A
(ru)
*
|
2006-10-17 |
2010-11-27 |
Юнилевер Н.В. (Nl) |
Аэрированный пищевой продукт и способ его приготовления
|
|
US20100186420A1
(en)
*
|
2006-10-17 |
2010-07-29 |
Mark John Berry |
Frozen aerated food product comprising surface-active fibres
|
|
RU2009118385A
(ru)
*
|
2006-10-17 |
2010-11-27 |
Юнилевер Н.В. (Nl) |
Пищевая композиция, содержащая пузырьки газа, и способ ее приготовления
|
|
US20100291280A1
(en)
*
|
2006-10-17 |
2010-11-18 |
Theodorus Berend Jan Blijdenstein |
Food composition comprising gas bubbles and process for preparing it
|
|
CN101528054B
(zh)
*
|
2006-10-17 |
2013-03-13 |
荷兰联合利华有限公司 |
包含气泡的食品组合物及其制备方法
|
|
CN1946120B
(zh)
*
|
2006-10-20 |
2010-05-12 |
华为技术有限公司 |
实现话单关联的方法及系统
|
|
WO2008065502A1
(en)
*
|
2006-11-29 |
2008-06-05 |
Pfizer Products Inc. |
Pharmaceutical compositions based on a) nanoparticles comprising enteric polymers and b) casein
|
|
JP5004333B2
(ja)
*
|
2006-12-08 |
2012-08-22 |
日機装株式会社 |
ナノオーダ粒子製造装置
|
|
US20090152176A1
(en)
*
|
2006-12-23 |
2009-06-18 |
Baxter International Inc. |
Magnetic separation of fine particles from compositions
|
|
TWI405590B
(zh)
|
2007-04-06 |
2013-08-21 |
活效製藥股份有限公司 |
微粉碎化有機化合物粒子之製法
|
|
US20100119612A1
(en)
*
|
2007-04-17 |
2010-05-13 |
Bend Research, Inc |
Nanoparticles comprising non-crystalline drug
|
|
WO2008135855A2
(en)
*
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
|
|
WO2008135852A2
(en)
*
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Pharmaceutical compositions comprising nanoparticles and casein
|
|
WO2008135828A2
(en)
*
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
|
US8426467B2
(en)
*
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
|
US8722736B2
(en)
*
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
|
US20080293814A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Deepak Tiwari |
Concentrate esmolol
|
|
US9545384B2
(en)
|
2007-06-04 |
2017-01-17 |
Bend Research, Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
|
|
EP2162120B1
(en)
*
|
2007-06-04 |
2016-05-04 |
Bend Research, Inc |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
|
US20100215747A1
(en)
*
|
2007-07-13 |
2010-08-26 |
Corey Jay Bloom |
Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
|
|
JP5307382B2
(ja)
*
|
2007-11-14 |
2013-10-02 |
日機装株式会社 |
微粒子化方法
|
|
US9233078B2
(en)
*
|
2007-12-06 |
2016-01-12 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
|
|
WO2009073215A1
(en)
*
|
2007-12-06 |
2009-06-11 |
Bend Research, Inc. |
Pharmaceutical compositions comprising nanoparticles and a resuspending material
|
|
US20100159010A1
(en)
*
|
2008-12-24 |
2010-06-24 |
Mutual Pharmaceutical Company, Inc. |
Active Agent Formulations, Methods of Making, and Methods of Use
|
|
US7828996B1
(en)
|
2009-03-27 |
2010-11-09 |
Abbott Cardiovascular Systems Inc. |
Method for the manufacture of stable, nano-sized particles
|
|
AU2010247800A1
(en)
|
2009-05-11 |
2011-12-15 |
Berg Llc |
Methods for the diagnosis of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
|
|
US20100294986A1
(en)
*
|
2009-05-19 |
2010-11-25 |
Massachusetts Institute Of Technology |
Supercritical fluid facilitated particle formation in microfluidic systems
|
|
US20100298602A1
(en)
*
|
2009-05-19 |
2010-11-25 |
Massachusetts Institute Of Technology |
Systems and methods for microfluidic crystallization
|
|
CN105168135A
(zh)
|
2010-03-12 |
2015-12-23 |
博格有限责任公司 |
辅酶Q10(CoQ10)的静脉内制剂及其使用方法
|
|
EP2550092B1
(de)
|
2010-03-22 |
2018-08-15 |
Instillo GmbH |
Verfahren zur herstellung von mikro- oder nanopartikeln
|
|
CA2832324C
(en)
|
2011-04-04 |
2022-03-15 |
Berg Llc |
Methods of treating central nervous system tumors
|
|
US10973763B2
(en)
|
2011-06-17 |
2021-04-13 |
Berg Llc |
Inhalable pharmaceutical compositions
|
|
WO2013056232A2
(en)
*
|
2011-10-13 |
2013-04-18 |
Case Western Reserve University |
Rxr agonists compounds and methods
|
|
CN104394850A
(zh)
|
2012-02-16 |
2015-03-04 |
布莱特赛德创新有限公司 |
膳食和营养组合物及应用的方法
|
|
US9901893B2
(en)
|
2013-03-28 |
2018-02-27 |
Instillo Gmbh |
Apparatus and method for producing dispersions and solids
|
|
SG10201903112WA
(en)
|
2013-04-08 |
2019-05-30 |
Berg Llc |
Treatment of cancer using coenzyme q10 combination therapies
|
|
KR102370843B1
(ko)
|
2013-09-04 |
2022-03-04 |
버그 엘엘씨 |
코엔자임 q10의 연속주입에 의한 암치료 방법
|
|
CA2959660A1
(en)
|
2014-09-03 |
2016-03-10 |
Genesegues, Inc. |
Therapeutic nanoparticles and related compositions, methods, and systems
|
|
FI20140266A7
(fi)
|
2014-10-06 |
2016-04-07 |
Nanoform Finland Oy |
Menetelmä ja laite nanopartikkeleiden valmistamiseksi
|
|
WO2017087576A1
(en)
|
2015-11-16 |
2017-05-26 |
Berg Llc |
Methods of treatment of temozolomide-resistant glioma using coenzyme q10
|
|
CN110115952B
(zh)
*
|
2018-02-05 |
2021-10-15 |
绍兴吉能纳米科技有限公司 |
一种可使用低温液化气体的高压均质方法
|
|
EP3972569A1
(en)
|
2019-05-23 |
2022-03-30 |
Helm AG |
Nanoparticles comprising enzalutamide
|
|
WO2021075003A1
(ja)
*
|
2019-10-16 |
2021-04-22 |
株式会社 ナノ・キューブ・ジャパン |
難溶性物質の超微粒子の分散液の製造方法
|
|
EP3884930A1
(en)
|
2020-03-23 |
2021-09-29 |
Bayer AG |
Nano-dry-melting
|
|
EP4651860A1
(en)
|
2023-01-18 |
2025-11-26 |
HELM Pharmaceuticals GmbH |
Crystalline nanoparticles comprising enzalutamide
|